Skip to main content

Table 2 Diagnostic performance of Fibrosis-4 (FIB-4) index for the detection of liver fibrosis

From: PNPLA3 genotype and fibrosis-4 index predict cardiovascular diseases of Japanese patients with histopathologically-confirmed NAFLD

Overall (n = 477)

AUROC

(95%CI)

Fib-4 cut off

Sensitivity (%)

Specificity (%)

PPV (%)

NPV (%)

Fibrosis stage 1–4 (n = 422) versus Fibrosis stage 0 (n = 55)

0.75

(0.69–0.81)

1.30

56.4

78.2

95.2

18.9

   

2.67

20.9

98.2

98.9

13.9

Fibrosis stage 2–4 (n = 233) versus Fibrosis stage 0–1 (n = 244)

0.84

(0.80–0.87)

1.30

79.8

73.8

74.4

79.3

   

2.67

36.1

98.0

94.4

61.6

Fibrosis stage 3–4 (n = 156) versus Fibrosis stage 0–2 (n = 321)

0.85

(0.81–0.88)

1.30

88.5

65.1

55.2

92.1

   

2.67

46.2

94.7

80.9

78.4

Fibrosis stage 4 (n = 35) versus Fibrosis stage 0–3 (n = 442)

0.90

(0.87–0.94)

1.30

100

51.4

14.0

100

   

2.67

82.9

86.4

32.6

98.5

  1. AUROC, area under the receiver-operating characteristic curve; CI, confidence interval; PPV, positive predictive value; NPV, negative predictive value